Table 4.
Use of proton pump inhibitors (PPIs), histamine receptor antagonists (H2RA), and antacids before and after the EsophyX-TIF procedure
| Medication | No. | Daily | Occasional | None |
|---|---|---|---|---|
| PPIs | ||||
| Pre-TIF | 86 | 86 (100%) | 0 | 0 |
| 6 Months | 81 | 14 (17%) | 11 (14%) | 56 (69%) |
| 12 Months | 79 | 12 (15%) | 13 (16%) | 54 (68%) |
| H2RA | ||||
| Pre-TIF | 86 | 3 (3%) | 1 (1%) | 82 (95%) |
| 6 Months | 81 | 0 | 1 (1%) | 80 (99%) |
| 12 Months | 79 | 0 | 5 (6%) | 74 (94%) |
| Antacids | ||||
| Pre-TIF | 86 | 0 | 18 (21%) | 68 (79%) |
| 6 Months | 81 | 0 | 21 (26%) | 60 (74%) |
| 12 Months | 79 | 0 | 23 (29%) | 56 (71%) |
| Any GERD medication | ||||
| Pre-TIF | 86 | 86 (100%) | 0 | 0 |
| 6 Months | 81 | 14 (17%) | 25 (31%) | 42 (52%) |
| 12 Months | 79 | 12 (15%) | 29 (37%) | 38 (48%) |
Usage was defined as “daily” when ≥ half dose was taken for ≥50% of the preceding follow-up period; as “occasional” when ≤ half dose taken for <50% of the preceding follow-up period; and as “none” when no medication was taken during the specified period
Values represent counts (%)